Department of Hepatobiliary Surgery, the First Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China.
PLoS One. 2014 Jan 15;9(1):e85077. doi: 10.1371/journal.pone.0085077. eCollection 2014.
Cigarette smoking is a potential risk factor for hepatocellular carcinoma (HCC) initiation, partially through interaction with hepatitis B virus (HBV). We examined the hypothesis that cigarette smoking might be associated with HBV-related HCC recurrence and patient survival after curative surgery.
Data of 302 patients with HBV infection who had undergone curative resection for HCC were prospectively collected from 2008 to 2011. Smoking status and smoking quantity (pack-years, PY) were asked at admission. Factors affecting recurrence-free survival (RFS) were examined. RFS and liver-specific mortality (LSM) stratified by risk factors were compared with log-rank test.
109 were current smokers. Current smokers were not different from non-smokers in tumor burden and surgical procedure. Univariate and multivariate analysis identified that heavy smoking (PY ≥ 20) was the most significant factor associated with HBV-related HCC recurrence after curative surgical resection (p = 0.001), followed by anti-HBV treatment (p<0.01), current smoking (p = 0.028), surgical margin <1 cm (p = 0.048) and blood transfusion >600 ml (p = 0.028). The median RFS in non-smokers, ex-smokers and current smokers was 34 months, 24 months and 26 months, respectively (p = 0.033). Current smokers had significantly worse RFS rate and increased 5-year cumulative LSM than non-smokers (p = 0.024, and p<0.001, respectively). Heavy smokers had significantly worse RFS than non- and light smokers (0<PY<20) (p<0.001, respectively) and higher cumulative LSM than non-smokers and light smokers (p = 0.003 and 0.001, respectively). Furthermore, in current smokers, continuing smoking postoperatively was strongly associated with poorer RFS and higher LSM than those who quit smoking postoperatively (p = 0.016 and p = 0.003, respectively).
Smoking history and quantity appears to be risk factors for HBV-related HCC recurrence and LSM of patients after surgery. For smokers, continued smoking postoperatively might accelerate tumor recurrence and patient death. Therefore, smoking abstinence should be strongly recommended to patients pre- and postoperatively.
吸烟是肝细胞癌(HCC)发生的潜在危险因素,部分原因是通过与乙型肝炎病毒(HBV)相互作用。我们检验了这样一个假设,即吸烟可能与 HBV 相关 HCC 复发以及根治性手术后患者的生存有关。
前瞻性收集了 2008 年至 2011 年间 302 例接受 HCC 根治性切除术的 HBV 感染患者的数据。入院时询问吸烟状况和吸烟量(包年,PY)。检查影响无复发生存(RFS)的因素。采用对数秩检验比较按危险因素分层的 RFS 和肝特异性死亡率(LSM)。
109 例为现吸烟者。现吸烟者与非吸烟者在肿瘤负担和手术方式上无差异。单因素和多因素分析确定,吸烟量大(PY≥20)是与 HBV 相关 HCC 根治性切除术后复发最显著的相关因素(p=0.001),其次是抗 HBV 治疗(p<0.01)、现吸烟(p=0.028)、手术切缘<1cm(p=0.048)和输血>600ml(p=0.028)。非吸烟者、曾吸烟者和现吸烟者的中位 RFS 分别为 34 个月、24 个月和 26 个月(p=0.033)。与非吸烟者相比,现吸烟者的 RFS 率显著降低,5 年累积 LSM 显著升高(p=0.024 和 p<0.001)。与非吸烟者和轻吸烟者(0<PY<20)相比,重度吸烟者的 RFS 明显更差(p<0.001,分别),累积 LSM 也更高(p=0.003 和 p=0.001,分别)。此外,在现吸烟者中,术后继续吸烟与 RFS 较差和 LSM 较高显著相关,与术后戒烟者相比(p=0.016 和 p=0.003)。
吸烟史和吸烟量似乎是与手术后 HBV 相关 HCC 复发和患者 LSM 相关的危险因素。对于吸烟者,术后继续吸烟可能会加速肿瘤复发和患者死亡。因此,应强烈建议患者在术前和术后戒烟。